Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

C2CD4C siRNA (Human)

SiRNA to inhibit C2CD4C expression using RNA interference

Product Specifications

Product Name Alternative

FAM148C; KIAA1957; NLF3; C2 calcium-dependent domain-containing protein 4C; Nuclear-localized factor 3; Protein FAM148C

Reactivity

H

Source

Synthetic

Applications

RNAi

Purity

> 97%

Form

Lyophilized powder

Components

We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human C2CD4C gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.

Storage Conditions

Shipped at 4 °C. Store at -20 °C for one year.

Specificity

C2CD4C siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.

NCBI Gene Symbol

C2CD4C

Quality Control

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

SwissProt (Human)

Q8TF44

Entrez GeneHuman

126567

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cholesterol-PEG-Mal (MW 400)
TCL-01904-01 10 mg

Cholesterol-PEG-Mal (MW 400)

Sign In for Pricing
View Details
Cholesterol-PEG-Mal (MW 400)
TCL-01904-02 50 mg

Cholesterol-PEG-Mal (MW 400)

Sign In for Pricing
View Details
(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin
OR1008115-01 100 mg

(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin

Sign In for Pricing
View Details
(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin
OR1008115-02 250 mg

(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin

Sign In for Pricing
View Details
(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin
OR1008115-03 1 g

(3aS,8aS) - (+) -4,4,8,8-Tetrakis (3,5-Di-I-Propylphenyl) Tetrahydro-2,2-Dimethyl-6-Phenyl-1,3-Dioxolo[4,5-e]Dioxaphosphepin

Sign In for Pricing
View Details
HLCS Antibody (FITC)
orb516439-01 50 µg

HLCS Antibody (FITC)

Sign In for Pricing
View Details